Gossamer Bio, Inc.
GOSS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $204,646 | $205,835 | $183,527 | $846,480 |
| - Cash | $46,074 | $32,109 | $111,973 | $183,403 |
| + Debt | $202,882 | $212,464 | $225,739 | $185,237 |
| Enterprise Value | $361,454 | $386,190 | $297,293 | $848,314 |
| Revenue | $114,701 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $114,701 | $0 | $0 | $0 |
| % Margin | 100% | – | – | – |
| EBITDA | -$39,967 | -$161,921 | -$211,069 | -$209,397 |
| % Margin | -34.8% | – | – | – |
| Net Income | -$56,528 | -$179,817 | -$229,378 | -$234,004 |
| % Margin | -49.3% | – | – | – |
| EPS Diluted | -0.25 | -1.18 | -2.84 | -3.33 |
| % Growth | 78.8% | 58.5% | 14.7% | – |
| Operating Cash Flow | -$3,468 | -$159,158 | -$187,032 | -$188,890 |
| Capital Expenditures | $0 | $0 | -$475 | -$1,621 |
| Free Cash Flow | -$3,468 | -$159,158 | -$187,507 | -$190,511 |